Related Experiment Video
Updated: Mar 24, 2026
Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
[STUDY OF PROTECTIVE ACTIVITY OF PROTEIN-CONTAINING ANTIGENS OF STREPTOCOCCUS PNEUMONIAE IN A HETEROLOGOUS SYSTEM]
Insights
Protein-containing antigens from specific Streptococcus pneumoniae serotypes demonstrated significant protective activity against heterologous strains in mouse models. These findings suggest pneumococcal proteins are key to cross-protection, not polysaccharide antigens.
Area of Science:
- Immunology
- Microbiology
- Vaccine Development
Context:
- Streptococcus pneumoniae (pneumococcus) causes significant global morbidity and mortality.
- Current vaccines primarily target polysaccharide antigens, but protein-based strategies are being explored.
- Understanding cross-protective antigens is crucial for developing broader-spectrum vaccines.
Purpose:
- To evaluate the protective efficacy of protein-containing antigens from various pneumococcal serotypes against infection by heterologous strains.
- To investigate the role of protein versus polysaccharide antigens in inducing cross-protection.
Summary:
- Protein-containing antigens isolated from Streptococcus pneumoniae serotypes 6B, 10A, 14, 19F, and 23F conferred 80-100% protection in mice against challenge with a heterologous serotype 3 strain.
- Antigens from serotypes 6B and 36R also showed 90% protection against the same challenge.
- These results indicate that pneumococcal proteins play a primary role in eliciting cross-protective immunity.
Impact:
- Suggests a potential shift towards protein-based antigens for more effective pneumococcal vaccines.
- Highlights specific serotypes whose protein components may be valuable vaccine targets.
- Provides evidence for the development of vaccines offering broader protection against diverse pneumococcal strains.
Aim:
Study protective activity of protein-containing antigens of pneumococcus, obtained from serotypes 6B, 10A, 14, 19F, 23F and 36R, against infection with heterologous strains of S. pneumoniae.
Materials And Methods:
S. pneumoniae strains of serotypes 3, 6B, 10A, 14, 19F, 23F and 36R, obtained from the collection of pneumococcus strains of Mechnikov RIVS, were used in the study. Protein-containing antigens of S. pneumoniae were isolated by acetone precipitations of supernatant fraction of culture medium. Protective activity of preparations of protein-containing antigens of pneumococcus as studied in experiments of active protection of BALb/c line mice.
Results:
The data obtained give evidence, that protein-containing antigens of pneumococcus, isolated from serotypes 6B, 10A, 14, 19F and 23F, effectively protect animals from subsequent infection with a heterologous S. pneumoniae strain of serotype 3 No. 11/56. Protection was noted at a level from 80 to 100% (p ≤ 0.05). Similar protective effect was detected in another experiment in a group of mice, immunized with preparations of protein-containing antigens of pneumococcus, obtained from serotypes 6B and 36R, against infection with a heterologous S. pneumoniae strain of serotype 3 No. 11/56. Protection was noted at a level of 90% (p ≤ 0.05).
Conclusion:
The results of the experiments carried out allow to assume, that the main role in formation of cross-protection in experiments in animals is played by pneumococcus, proteins, that are a part of the studied preparations, and not polysaccharide antigens.
Related Concept Videos
01:26Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
00:42Cross-reactivity